Mouse Interferon-gamma Recombinant
$70.00 – $1,000.00
accession | P01580 |
Source | Optimized DNA sequence encoding Mouse Interferon gamma mature chain was expressed in Escherichia Coli. |
Molecular weight | Native Mouse IFN-g, generated by the proteolytic removal of the signal peptide and propeptide, the molecule has a calculated molecular mass of approximately 16kDa. Recombinant Interferon gamma is a monomer protein consisting of 134 amino acid residue subunits, and migrates as an approximately 16kDa protein under non-reducing and reducing conditions in SDS-PAGE. |
Purity | >95%, as determined by SDS-PAGE and HPLC |
Biological Activity | The ED(50) was determined by the cytopathic inhibition assay with murine L929 cells challenged with EMC virus was found to be.1 ng/ml |
Protein Sequence | MNATHCILAL QLFLMAVSGC YCHGTVIESL ESLNNYFNSS GIDVEEKSLF LDIWRNWQKD GDMKILQSQI ISFYLRLFEV LKDNQAISNN ISVIESHLIT TFFSNSKAKK DAFMSIAKFE VNNPQVQRQA FNELIRVVHQ LLPESSLRKR KRSRC |
Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
Presentation | Recombinant mouse IFN-g was lyophilized from a.2 μm filtered PBS solution. |
Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers. |
Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
Biological Process | Antiviral-defense |
Biological Process | Growth-regulation |
Molecular function | Cytokine |
Methods
Cardiac adherent proliferating cells reduce Coxsackievirus B3 viral progeny release in a nitric oxide- and interleukin-10-dependent manner and require interferon-γ priming. |
Cardiac adherent proliferating cells reduce Coxsackievirus B3 viral progeny release in a nitric oxide- and interleukin-10-dependent manner and require interferon-γ priming. |
Cytokine measurements
|
Cytokine Assays
|
Cell culture
Read more |